BCRP efflux
Selected indexed studies
- Intestinal Efflux Transporters P-gp and BCRP Are Not Clinically Relevant in Apixaban Disposition. (Pharm Res, 2020) [PMID:32996065]
- Transcription factor-mediated regulation of the BCRP/ABCG2 efflux transporter: a review across tissues and species. (Expert Opin Drug Metab Toxicol, 2020) [PMID:32077332]
- Wogonin effects on the efflux transporters BCRP and MRP2, explain its effectiveness in ulcerative colitis: Implications for metabolic and transport interactions. (Pharmacol Res, 2025) [PMID:39746499]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- Intestinal Efflux Transporters P-gp and BCRP Are Not Clinically Relevant in Apixaban Disposition. (2020) pubmed
- Transcription factor-mediated regulation of the BCRP/ABCG2 efflux transporter: a review across tissues and species. (2020) pubmed
- Wogonin effects on the efflux transporters BCRP and MRP2, explain its effectiveness in ulcerative colitis: Implications for metabolic and transport interactions. (2025) pubmed
- In-vitro Assessment of BCRP-Mediated Efflux of Antiseizure Medications in Human Blood-Brain Barrier Cell Model. (2025) pubmed
- Utilizing a Dual Human Transporter MDCKII-MDR1-BCRP Cell Line to Assess Efflux at the Blood Brain Barrier. (2024) pubmed
- Protective role of the placental efflux transporter BCRP/ABCG2 in the relationship between prenatal cadmium exposure, placenta weight, and size at birth. (2023) pubmed
- Ensemble Machine Learning Approaches Based on Molecular Descriptors and Graph Convolutional Networks for Predicting the Efflux Activities of MDR1 and BCRP Transporters. (2023) pubmed
- Role of the efflux transporters BCRP and MRP1 in human placental bio-disposition of pravastatin. (2018) pubmed
- Kaempferol suppression of acute colitis is regulated by the efflux transporters BCRP and MRP2. (2022) pubmed
- Cannabis constituents interact at the drug efflux pump BCRP to markedly increase plasma cannabidiolic acid concentrations. (2021) pubmed